Immunogenicity and Safety Study of 1 and 2 Doses of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine MenACWY-TT (GSK134612) in Toddlers, Persistence up to 5 Years After Vaccination and Co-administration With Pfizer's Prevenar 13™Vaccine
Clinical trial NCT01939158 · COMPLETED
Trial details
- NCT number
- NCT01939158
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-02
- Primary completion
- 2019-12-05
- Enrollment
- 803
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.